arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

AETHLON MEDICAL INC

AEMD
$3.11 ▲ +0.09 (+2.98%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
63 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

AETHLON MEDICAL INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -31.2%
FCF / Share None
Trailing P/E 7.8x
Price / Book 1.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

63-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$574.25K
↑ +4278.2%
Net Income Profit after all expenses
$-1.88M
↑ +69.9%
Operating Margin Operating profit as % of sales
-431.5%
↓ -10.3%
FCF / Share Free cash flow per share
$-2.28
↑ +45.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
3
Cash Quality
57

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 63 quarters